Evaluation of the preventive effect of landiolol on postoperative atrial fibrillation

Evaluation of the preventive effect of landiolol on postoperative atrial fibrillation - PELTA(Preventive effect of landiolol on postoperative atrial fibrillation) study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003378

Enrollment

150

Registered

2010-03-25

Start date

2010-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative atrial fibrillation

Interventions

Administration landiolol (1micro-g/kg/min) depending on assignment Administration landiolol (2micro-g/kg/min) depending on assignment Usual care(not administrate landiolol before atrial fibrilla

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: *all elective cases in our department (cardiac and aortic surgery)

Exclusion criteria

Exclusion criteria: *existence of severe bronchial asthma *existence of severe DM *persistent atrial fibrillation before entering ICU

Design outcomes

Primary

Measure	Time frame
Occurrence of postoperative atrial fibrillation Evaluation UCG,inflammatory marker	—

Secondary

Measure	Time frame
Ventilation time ICU days *Hospital days	—

Countries

Japan

Contacts

Public ContactYoshikatsu Saiki

Tohoku University Hospotal Cardiovascular Surgery

yoshisaiki@med.tohoku.ac.jp022-717-7222

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026